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PHYSIOLOGICAL ROLE OF ADIPOSE TIS-
SUE IN ENERGY BALANCE
Evolutionally, humans have developed the ability
to store excess calorie intake in adipose tissue as
fat, which can be used in times of famine (1). Die-
tary fat absorbed into epithelial cells of the intestines
is assembled into one type of lipoprotein, chylomi-
crons, enters the bloodstream, and is transported
to peripheral tissues. Lipoprotein lipase (LPL) in adi-
pocytes, one of the main destinations of chylomi-
crons, hydrolyses triglyceride (TG) in chylomicrons
into free fatty acids (FFAs) and glycerol. Adipocyte
LPL also hydrolyses TG in VLDL (very low den-
sity lipoprotein), supplied from the liver and in rem-
nants of both chylomicrons and VLDL, into FFAs
and glycerol. Adipocytes take up FFAs and glycerol
and reassemble them into TG and store it in lipid
droplets (2). When necessary, stored TG in adipo-
cytes can be hydrolysed by their adipose triglyceride
lipase (ATGL) and hormone-sensitive lipase (HSL)
(3), and used as energy, which may help individuals
in situations where the caloric intake falls short of
its demand. Due to a robust food supply and seden-
tary life style in industrialized nations, the amount
of caloric intake exceeds that of calorie demand in
many individuals. Thus, white adipose tissue (WAT)
in these individuals keep accumulating TG and grow-
ing both in size and in number, resulting in obesity
and even type 2 diabetes through the development
of insulin resistance (4).
PHYSIOLOGICAL ROLE OF ADIPOSE TIS-
SUE IN ENDOCRINE SYSTEM
Recent studies have revealed that adipose tissue
not only serves as a storage site for fat but also
functions as an endocrine organ by secreting a
wide range of hormones and cytokines (2, 5). For
instance, leptin production by adipocytes, which is
upregulated in large adipocytes (6), regulates food
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intake and fat mass through its action in the hypo-
thalamus, resulting in decreased hunger and stimu-
lated energy expenditure (7, 8). Leptin also in-
creases lipid oxidation in the liver and lipolysis in
skeletal muscle and adipocytes to control whole-
body energy balance (9, 10). Adiponectin is exclu-
sively produced by adipocytes and secreted into the
bloodstream, where it self assembles into larger
structures (trimer, hexamer and high-molecular
weight forms). A proteolytic cleavage product of adi-
ponectin, known as globular adiponectin, also circu-
lates in human plasma (11). Although the biological
activities of these isoforms are controversial, it ap-
pears that high-molecular weight adiponectin has
a mainly beneficial role in humans and rodents (12,
13). In these studies, high-molecular weight adi-
ponectin improved insulin sensitivity by inhibiting
hepatic glucose production and enhancing glucose
uptake into skeletal muscle. It also increased lipid
oxidation in both the liver and skeletal muscle (14).
ADIPOSE TISSUE DYSFUNCTION IN OBE-
SITY
A negative impact of excess plasma free fatty ac-
ids or triglycerides, including cellular dysfunction
and programmed cell death, has been reported in a
number of non-adipose tissues (15, 16). Thus, hy-
pertrophy (increased cell size) and hyperplasia (in-
creased cell number) of WAT to store more TG in
their intracellular lipid droplets is a protective mecha-
nism against calorie overload. However, the capacity
of WAT to synthesize TG from FFAs is not infinite.
Challenging adipocytes with an excess amount of
FFAs saturates the biosynthetic pathway of TG in
adipocytes, and FFAs start to accumulate in adipo-
cytes. FFAs accumulated in adipocytes pose endo-
plasmic reticulum stress (ER stress) and oxidative
stress at the level of the mitochondrion, both of
which cause dysfunction in adipocytes (17). Affected
adipocytes have decreased TG synthesis and in-
creased lipolysis, which results in the systemic re-
lease of FFAs. In addition, hormones and cytokines
produced and released by these adipocytes are dif-
ferent from those by healthy adipocytes. Secretion
of adiponectin is attenuated, whereas that of proin-
flammatory cytokines such as interleukin-6 (IL-6),
tumor necrosis factor α (TNFα) and monocyte che-
motactic protein-1 (MCP-1) is elevated, which re-
cruits macrophages into WAT, causing chronic low-
grade inflammatory responses (18). Dysfunctional
adipocytes due to overloading of FFAs die and re-
lease their contents, which recruits neutrophils and
macrophages into WAT and promotes a chronic
low-grade inflammatory response in WAT (19, 20).
As a result, the plasma level of inflammatory cytoki-
nes goes up and affects other tissues as well, such
as liver, skeletal muscle, cardiac muscle and blood
vessels, which eventually leads to insulin resistance
and atherosclerosis (17).
SATURATED FATTY ACID CONSUMPTION
Among dietary fat constituents, saturated fat,
which contains saturated fatty acids (SFA), is draw-
ing particular attention these days, since a strong
correlation between SFA intake and the metabolic
syndrome, which exhibits insulin resistance, has
been reported (21-23). Foods that contain a high
level of SFA are dairy products, fatty meats, palm
oil, coconut oil and some processed foods (24). Al-
though overconsumption of FFAs generally leads
to chronic low-grade inflammation in WAT, as de-
scribed above, SFAs exhibit a particularly strong ef-
fect to induce WAT inflammation (25).
SFA-INDUCED INSULIN RESISTANCE
AND INFLAMMATORY RESPONSE IN WAT
Overloading of adipocytes with SFAs, transported
from the bloodstream presumably by CD36/FAT,
results in accumulation of diacylglycerol (DAG),
which in turn activates protein kinase C (PKC) θ
and desensitizes adipocytes to insulin stimulation
(26, 27). PKCθ activates the I-kappa-B kinase (IKK)
and c-Jun N-terminal kinase (JNK) pathways, which
induces serine phosphorylation and degradation of
IRS-1 and stimulates production and secretion of
proinflammatory cytokines (28). Overloading SFAs
also results in accumulation of ceramide in adipo-
cytes, which is reported to activate IKK and JNK,
as well (29, 30). Accelerated β -oxidation of SFAs
causes excess electron flux in the mitochondrial res-
piratory chain, resulting in increased production of
reactive oxygen species (ROS), which was reported
to cause insulin resistance and an inflammatory re-
sponse in adipocytes (31). Furthermore, SFAs acti-
vate Toll-like receptor 4 (TLR4) on the surface of
adipocytes, which activates the NFκB pathway and
JNK pathway (32, 33). Thus, SFAs both transported
into adipocytes and bound to TLR4 impair insulin
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signaling and stimulate secretion of proinflammatory
factors from adipocytes.
CROSSTALK BETWEEN ADIPOCYTES
AND MACROPHAGES IN SFA-INDUCED
INSULIN RESISTANCE
In obesity, hypertrophied adipocytes in WAT se-
crete proinflammatory cytokines (called adipokines,
as they are produced in and released from adipo-
cytes), such as MCP-1, which recruit macrophages
into WAT. SFAs released from hypertrophied adipo-
cytes bind to TLR4 on the surface of macrophages,
and together with adipokines, activate macrophages.
As a result, active macrophages in WAT stimulate
the NFκB pathway to produce and secrete cytoki-
nes that impair the insulin signaling and further
potentiate inflammation in adipocytes (33). In fact,
TLR4 knockout mice failed to develop high fat diet-
induced insulin resistance, due to a lack of NFκB
activation, both in adipocytes and macrophages
(34). Thus, infiltration of macrophages into WAT
and crosstalk between adipocytes and macrophages
through their SFA-TLR4-NFκB pathways are crucial
for the development of SFA-induced chronic low-
grade inflammation and insulin resistance in WAT.
SFA-INDUCED CHRONIC LOW-GRADE
INFLAMMATION IN WAT CAUSES INSU-
LIN RESISTANCE IN NON-ADIPOSE TIS-
SUES
SFA-induced chronic low-grade inflammation and
insulin resistance in WAT affects other tissues and
impairs their sensitivity to insulin, as well. SFA over-
flow from WAT is taken up by myotubes and hepa-
tocytes, and accumulates in them. Similar to adipo-
cytes, SFAs in myotubes activate signal transduction
pathways through IKK and JNK, which causes ser-
ine phosphorylation and degradation of IRS-1 and
desensitizes myotubes to insulin stimulation (35-
38). NFκB activation by binding of SFA to TLR4 is
also reported in myotubes (39). Since skeletal mus-
cle accounts for the majority of insulin-stimulated
whole body glucose uptake, impaired insulin signal-
ing in skeletal muscle causes marked insulin resis-
tance (40).
SFA-induced serine phosphorylation and degra-
dation of IRS-1 are also observed in hepatocytes,
which lead to less insulin-regulated inhibition of
hepatic glucose production and increased fasting gly-
cemia (41). SFA is also reported to induce apoptosis
of hepatocytes through the JNK pathway (42).
CONCLUSION
Cellular dysfunction of adipocytes in WAT due to
overloading of SFAs into them, designated ‘lipotoxic-
ity’, is a chronic low-grade inflammation of WAT. It
not only impairs insulin signaling in WAT, but also
affects insulin signaling in remote tissues, resulting
in whole body insulin resistance. Lipotoxicity by
SFAs is one of the underlying pathophysiological
mechanisms of obesity and type 2 diabetes.
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